Unlocking the Potential of Minor Cannabinoids Through Innovative Genetics & Research

Unlocking the Potential of Minor Cannabinoids Through Innovative Genetics & Research

Watch a snapshot of our Unlocking the Potential of Minor Cannabinoids Through Innovative Genetics & Research discussion from GCI Virtual Summit (June, 2021) with Dr. Ethan Russo, Founder & CEO of CReDO Science – hosted by Global Cannabis Intelligence.

To meet, network and collaborate with global cannabis and psychedelic leaders, check out the GCI Summit.

To explore additional cannabis content, click here.

Previous articleClinical Trial Treating Anxiety with Psilocybin Approved in Australia
Next articleTraining Psychedelic Therapists